openPR Logo
Press release

Fibromyalgia Treatment Market is Expected to Witness High Growth in the Forecast Period 2017 - 2027

05-31-2017 07:20 AM CET | Health & Medicine

Press release from: Transparency Market Research

Fibromyalgia Treatment Market is Expected to Witness High

Fibromyalgia disorder is characterized by musculoskeletal pain along with characteristics of fatigue, sleep disorders, memory and mood issues, irritable bowel syndrome, headaches, depression, and anxiety. It is believed that fibromyalgia alters the pain sensations mechanism controlled by the brain. An individual with fibromyalgia also can have symptoms such as tension headaches, migraine, temporomandibular joint (TMJ) disorders. Symptoms of fibromyalgia can be gradually accumulated with the time, or it can be done by some external factors such as physical trauma, infection, psychological stress, and surgery. However, the real cause of fibromyalgia is still unknown. Prevalence of fibromyalgia is more common in women than in men, and it can be nine times higher in women compare to men.

Obtain Report Details @ http://www.transparencymarketresearch.com/fibromyalgia-treatment-market.html

Fibromyalgia treatment market is expected to witness high growth over the forecast period as the number of trauma cases and surgeries are increasing across the globe. Although there is no cure for fibromyalgia, however, some drugs in fibromyalgia treatment are used to reduce the symptoms of fibromyalgia such as narcotic and non-narcotic analgesics, anticonvulsants, antidepressants, and muscle relaxants. As fibromyalgia associated with age, increase in geriatric population across the globe is also a factor to increase in the prevalence of fibromyalgia, which in turn, likely to boost the growth of fibromyalgia treatment market.

Fibromyalgia is hard to diagnose as most of the symptoms are associated with other diseases as well, which in turn lower the diagnosis rate of patients having fibromyalgia in turn hampering the growth of fibromyalgia treatment market. Fibromyalgia treatment Combination therapies to treat fibromyalgia has many side effects and can cause severe damage to the patients. Also, other indications such as diabetes, kidney problem, heart disease can lead to severe damage to the patients if these drugs are used in fibromyalgia treatment. These factors are expected to hinder the growth of fibromyalgia treatment market over the forecast period.

Fibromyalgia is diagnosed with the chronic pain symptoms at tender points, a person has fibromyalgia if he or she has pain in at least 11 of 18 specific tender point sites. However, fibromyalgia treatment involves the high rate of chances of misdiagnosis if the individual does not meet the criteria of ACR. The introduction of new drugs is expected to boost the growth of fibromyalgia treatment market over the forecast period. Most of the drugs in fibromyalgia treatment are prescribed as off-label as these drugs available for other indications in the market such as including antidepressants, opioids, anti-epileptics and muscle relaxants.

According to the European Network of Fibromyalgia Associations (ENFA), around 14 million people are affected in Europe by fibromyalgia and approximately 400 million people globally. Along with drug therapies, fibromyalgia treatment includes aerobic exercise which is also recommended to lower the pain and relieve the stress in fibromyalgia patients.

The fibromyalgia treatment market covers the market scenario for North America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Latin America and MEA. There are very few players with approved drugs in the fibromyalgia treatment market giving opportunities for emerging players for market entry. U.S. is the biggest market for fibromyalgia treatment.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22697

As North America is strong in terms of international company presence and also active research and development investments coupled with an increase in healthcare expenditure, the North America fibromyalgia treatment market contributes maximum revenue share in global fibromyalgia market. With the increasing number of approvals for new drugs in future, fibromyalgia market is expected to grow faster in developed and emerging economies.

Some of the participants in fibromyalgia treatment market include Daiichi Sankyo, Eli Lilly, Innovative Med Concepts, Pfizer, Theravance Biopharma, Forest Pharmaceuticals, Inc., Innovative Med Concepts, Meiji Seika Pharma, and Tonix Pharmaceuticals. The fibromyalgia treatment market is competitive in nature as many generic drugs are available and used as off-label. Leading companies in fibromyalgia treatment are focusing on various new drug development and expanding their operation in the new countries for maintaining their foothold in the fibromyalgia treatment market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibromyalgia Treatment Market is Expected to Witness High Growth in the Forecast Period 2017 - 2027 here

News-ID: 557011 • Views: 306

More Releases from Transparency Market Research

Global Waste to Energy Market is Presumed to be Valued at US$ 32 Bn by 2026
Overview TMR’s report on the Waste-to-energy Technologies Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Waste-to-energy Technologies Market serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Waste-to-energy Technologies Market over the forecast period.
FPSO Market is Likely to Reach a Value of US$ 66 Bn by 2026
Overview TMR’s report on the FPSO Vessels and Equipments Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the FPSO Vessels and Equipments Market serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the FPSO Vessels and
Recycled Plastic & Plastic Waste to Oil Market Demand and Growth Analysis with F …
Overview TMR’s report on the Recycled Plastics & Plastic Waste to Oil Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Recycled Plastics & Plastic Waste to Oil Market serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely
Chlorinated Paraffins Market – Size will Observe Lucrative Surge by the End202 …
Overview TMR’s report on the Chlorinated Paraffin Market is an all-important tool for stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Chlorinated Paraffin Market serves as a valuable guide for stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Chlorinated Paraffin Market over the forecast period.

All 5 Releases


More Releases for Fibromyalgia

Anticonvulsant Market for Fibromyalgia Competitive Analysis and Forecast 2017-20 …
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsant are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Fibromyalgia Treatment Market Trends, Outlook, and Opportunity Analysis, 2018-20 …
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual with fibromyalgia can also have symptoms such as headaches, poor concentration and depression. Fibromyalgia symptoms
Fibromyalgia Treatment Market Global Industry Insights 2018-2026
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. An individual with fibromyalgia can also have symptoms such as headaches, poor concentration and depression. Fibromyalgia symptoms
Fibromyalgia Treatment Market Global Opportunity Analysis, 2018-2026
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue and localized tenderness affecting individuals mentally, physically and socially. Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle pain and tender points. Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1691 An individual with fibromyalgia can also have symptoms such
Anticonvulsant Market for Fibromyalgia Optimistic Opportunities 2025
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Fibromyalgia Treatment Market | SWOT Analysis of Major Market Segments
Fibromyalgia disorder is characterized by musculoskeletal pain along with characteristics of fatigue, sleep disorders, memory and mood issues, irritable bowel syndrome, headaches, depression, and anxiety. It is believed that fibromyalgia alters the pain sensations mechanism controlled by the brain. An individual with fibromyalgia also can have symptoms such as tension headaches, migraine, temporomandibular joint (TMJ) disorders. Symptoms of fibromyalgia can be gradually accumulated with the time, or it can be